Befejeződött1. fázis
A study to investigate safety, tolerability, pharmacokinetics and efficacy of REM0045392 compared with placebo in healthy participants
Key facts
- Where
- Edegem, BelgiumSee the site
- Phase
- 1. fázis
Where in Belgium
- SGS BelgiumEdegem, BelgiumNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Remynd
- Trial code
- EU 2025-520454-11-00
- Record updated
- 2025. november 12.